Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 36 citing articles:

Advances in Osteosarcoma
Isidora Panez-Toro, Javier Muñoz-García, Jorge William Vargas-Franco, et al.
Current Osteoporosis Reports (2023) Vol. 21, Iss. 4, pp. 330-343
Open Access | Times Cited: 72
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression
Lixia Li, Dewei Liu, Tingting Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1
Xianfu Wei, Jinyan Feng, Long Chen, et al.
Cancer Letters (2024), pp. 217194-217194
Closed Access | Times Cited: 4
The Role of Epithelial–Mesenchymal Transition in Osteosarcoma Progression: From Biology to Therapy
Adriana Pătrașcu, Elena Ţarcă, Ludmila Lozneanu, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 644-644
Open Access
Toward quantification of hypoxia using fluorinated Eu II/III -containing ratiometric probes
S. A. Amali S. Subasinghe, Caitlyn J. Ortiz, Jonathan Romero, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 15
Open Access | Times Cited: 10
Hypoxia Compromises the Differentiation of Human Osteosarcoma Cells to CAR-R, a Hydroxylated Derivative of Lithocholic Acid and Potent Agonist of the Vitamin D Receptor
H. M. Evans, Alexander Greenhough, Laura Perry, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 365-365
Open Access
Anoikis-related PLCB4 is linked to immunotherapy response in osteosarcoma
Liu G, Fang Yu, Jiamiao Li, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
An immune escape-related gene signature for predicting the prognostic and immune microenvironment in osteosarcoma
Meng Chen, Chuan Li, Yongqing Xu
Archives of Medical Science (2025)
Open Access
Epigenetic Inactivation of RIPK3-Dependent Necroptosis Augments Cisplatin Chemoresistance in Human Osteosarcoma
Aditya Sharma, Daniel Pettee, Christine Mella, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3863-3863
Open Access
A catalase-powered self-oxygen-generating soft nanomotor for photodynamic therapy of osteosarcoma
Xinyi Tan, Yu Wang, Ying Yuan, et al.
Materials Today Bio (2025) Vol. 32, pp. 101796-101796
Open Access
Upregulated ATG4B predicts poor prognosis and correlates with angiogenesis in osteosarcoma
Elzahraa Ibrahim Mohamed Khalil, Fatma El Zahraa Ammar Mohamed, Rehab Mohamed
Journal of the Egyptian National Cancer Institute (2025) Vol. 37, Iss. 1
Open Access
Mechano-induced cell metabolism disrupts the oxidative stress homeostasis of SAOS-2 osteosarcoma cells
Giuseppina Fanelli, Giulia Alloisio, Veronica Lelli, et al.
Frontiers in Molecular Biosciences (2024) Vol. 10
Open Access | Times Cited: 3
Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma
John O’Donoghue, Fiona E. Freeman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Spatiotemporal evolutionary process of osteosarcoma immune microenvironment remodeling and C1QBP‐driven drug resistance deciphered through single‐cell multi‐dimensional analysis
Xin Wu, Ning Tang, Qiangqiang Zhao, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 2
Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Yonghua Zhu, Jingyao She, Rong Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin
Chuanhua Cao, Pei Yu, Haiying Yu, et al.
Journal of Chemotherapy (2023) Vol. 36, Iss. 2, pp. 156-166
Closed Access | Times Cited: 6
NEK6 Promotes the Progression of Osteosarcoma Through Activating STAT3 Signaling Pathway by Down-Regulation of miR-26a-5p
Min Zhu, Yuyu Sun, Huawei Xue, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 2831-2848
Open Access | Times Cited: 5
In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma
Hai Huang, Xiaonan Wang, Shuling Zhang, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111226-111226
Closed Access | Times Cited: 4
Cellular crosstalk in the bone marrow niche
Zeqi Huang, Zoya Iqbal, Zhe Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
GsMTx-4 venom toxin antagonizes biophysical modulation of metastatic traits in human osteosarcoma cells
Arianna Buglione, Giulia Alloisio, Chiara Ciaccio, et al.
European Journal of Cell Biology (2024) Vol. 104, Iss. 1, pp. 151469-151469
Open Access | Times Cited: 1
Advances in drug resistance of osteosarcoma caused by pregnane X receptor
Kunhong Mao, Can Liu, Zhongwen Tang, et al.
Drug Metabolism Reviews (2024), pp. 1-14
Closed Access | Times Cited: 1
The efficacy and applicability of chimeric antigen receptor (CAR) T cell-based regimens for primary bone tumors: A comprehensive review of current evidence
Atefeh Barzegari, Fateme Salemi, Amirhossein Kamyab, et al.
Journal of bone oncology (2024) Vol. 48, pp. 100635-100635
Open Access | Times Cited: 1
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
Michael J. Robinson, Elizabeth J. Davis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 11, pp. 1366-1373
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top